DMAC
Price
$5.26
Change
-$0.12 (-2.23%)
Updated
Dec 24 closing price
90 days until earnings call
KLTO
Price
$0.47
Change
+$0.05 (+11.90%)
Updated
Dec 24 closing price
Ad is loading...

DMAC vs KLTO

Header iconDMAC vs KLTO Comparison
Open Charts DMAC vs KLTOBanner chart's image
DiaMedica Therapeutics
Price$5.26
Change-$0.12 (-2.23%)
Volume$51.99K
CapitalizationN/A
Klotho Neurosciences
Price$0.47
Change+$0.05 (+11.90%)
Volume$73.14K
CapitalizationN/A
DMAC vs KLTO Comparison Chart
Loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DMAC vs. KLTO commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a Hold and KLTO is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (DMAC: $5.26 vs. KLTO: $0.47)
Brand notoriety: DMAC and KLTO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 49% vs. KLTO: 14%
Market capitalization -- DMAC: $224.92M vs. KLTO: $10.93M
DMAC [@Biotechnology] is valued at $224.92M. KLTO’s [@Biotechnology] market capitalization is $10.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whileKLTO’s FA Score has 0 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • KLTO’s FA Score: 0 green, 5 red.
According to our system of comparison, DMAC is a better buy in the long-term than KLTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 6 TA indicator(s) are bullish while KLTO’s TA Score has 6 bullish TA indicator(s).

  • DMAC’s TA Score: 6 bullish, 4 bearish.
  • KLTO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, DMAC is a better buy in the short-term than KLTO.

Price Growth

DMAC (@Biotechnology) experienced а +1.15% price change this week, while KLTO (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

DMAC is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DMAC($225M) has a higher market cap than KLTO($10.9M). DMAC YTD gains are higher at: 85.211 vs. KLTO (-95.607). KLTO has higher annual earnings (EBITDA): -618.2K vs. DMAC (-24.07M). DMAC has more cash in the bank: 50.2M vs. KLTO (50.9K). KLTO has less debt than DMAC: KLTO (151K) vs DMAC (365K). DMAC (0) and KLTO (0) have equivalent revenues.
DMACKLTODMAC / KLTO
Capitalization225M10.9M2,064%
EBITDA-24.07M-618.2K3,894%
Gain YTD85.211-95.607-89%
P/E RatioN/AN/A-
Revenue00-
Total Cash50.2M50.9K98,625%
Total Debt365K151K242%
FUNDAMENTALS RATINGS
DMAC: Fundamental Ratings
DMAC
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
72
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DMACKLTO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
41%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
46%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 6 days ago
36%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
23%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
19%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 9 days ago
50%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
11%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
DMAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DURPX24.990.20
+0.81%
DFA US Hi Relatv Profitability Instl
HSZYX6.450.04
+0.62%
NexPoint Climate Tech Y
IIGZX11.780.06
+0.51%
Voya Global High Dividend Low Vol Port I
FMUAX14.840.06
+0.41%
Federated Hermes Muni and Stock Adv A
MSACX15.690.03
+0.19%
Morgan Stanley Inst Passport ovrs eq I

DMAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with AADI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then AADI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
-2.14%
AADI - DMAC
38%
Loosely correlated
+4.90%
AVXL - DMAC
26%
Poorly correlated
-2.77%
PCVX - DMAC
26%
Poorly correlated
-1.34%
STTK - DMAC
24%
Poorly correlated
+0.91%
VTGN - DMAC
23%
Poorly correlated
-0.78%
More

KLTO and

Correlation & Price change

A.I.dvisor tells us that KLTO and DYAI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KLTO and DYAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLTO
1D Price
Change %
KLTO100%
+10.85%
DYAI - KLTO
24%
Poorly correlated
-2.79%
HCWB - KLTO
22%
Poorly correlated
-0.20%
ZVSA - KLTO
21%
Poorly correlated
-1.71%
PRTG - KLTO
21%
Poorly correlated
-3.71%
DMAC - KLTO
20%
Poorly correlated
-2.14%
More